goserelin

The drug is used for the treatment of prostate cancer (metastatic, locally advanced, and other forms), breast cancer, endometriosis, uterine fibroids, as well as for preparation for in vitro fertilization procedures and endometrial thinning.

Form: implant

ATC: L02AE03

Manufacturer: AMV GmbH (manufacturing "in bulk", primary and secondary packaging, batch control, responsible for batch release)

The drug is used to treat prostate cancer, endometriosis, uterine fibroids, as well as breast cancer in women during the perimenopausal period.

Form: implant

ATC: L02AE03

Manufacturer: AMV GmbH (manufacturing "in bulk", primary and secondary packaging, batch control, responsible for batch release)

The drug is used for the treatment of prostate cancer (metastatic, locally advanced, as well as adjuvant therapy), breast cancer, endometriosis, uterine fibroids, as well as for the preoperative thinning of the endometrium and in preparation for in vitro fertilization.

Form: implant

ATC: L02AE03

Manufacturer: Synergy Health Daniken AG (sterilization)

The drug is used for the therapy of prostate cancer, endometriosis, uterine fibroids, as well as breast cancer in women during the perimenopausal period.

Form: implant

ATC: L02AE03

Manufacturer: Synergy Health Daniken AG (sterilization)

The drug is used for the treatment of prostate cancer (metastatic, locally advanced, or as adjuvant therapy), breast cancer in women during the pre- and perimenopausal period, as well as for the treatment of endometriosis, uterine fibroids, endometrial thinning, and preparation for in vitro fertilization.

Form: capsules, prolonged-release for subcutaneous administration

ATC: L02AE03

Manufacturer: AstraZeneca UK Limited

The drug is used for the therapy of prostate cancer, endometriosis, uterine fibroids, as well as breast cancer in women during the perimenopausal period.

Form: capsules, prolonged-release for subcutaneous administration

ATC: L02AE03

Manufacturer: AstraZeneca UK Limited